Leukemia Research
Volume 26, Issue 10 , Pages 933-938 , October 2002

Differential effects of fibroblast growth factor-4, epidermal growth factor and transforming growth factor-β1 on functional development of stromal layers in acute myeloid leukemia

Received 10 September 2001 ,Accepted 9 February 2002.

References 

  1. Duhrsen U, Hossfeld DK. Stromal abnormalities in neoplastic bone marrow diseases. Ann. Hematol. 1996;73:53–70
  2. Mayani H. Composition and function of the hemopoietic microenvironment in human myeloid leukemia. Leukemia. 1996;10:1041–1047
  3. Dooley DC, Oppenlander BK, Spurgin P, Mead JH, Novak FP, Plunkett M, et al.  Basic fibroblast growth factor and epidermal growth factor downmodulate the growth of hematopoietic cells in long-term stromal cultures. J. Cell. Physiol. 1995;165:386–397
  4. Kimura A, Katoh O, Kuramoto A. Effects of platelet derived growth factor, epidermal growth factor and transforming growth factor-beta on the growth of human marrow fibroblasts. Br. J. Haematol. 1988;69:9–12
  5. Kimura A, Katoh O, Hyodo H, Kuramoto A. Transforming growth factor-beta regulates growth as well as collagen and fibronectin synthesis of human marrow fibroblasts. Br. J. Haematol. 1989;72:486–491
  6. Wilson EL, Rifkin DB, Kelly F, Hannocks MJ, Gabrilove JL. Basic fibroblast growth factor stimulates myelopoiesis in long-term human bone marrow cultures. Blood. 1991;77:954–960
  7. Quito FL, Beh J, Bashayan O, Basilico C, Basch RS. Effects of fibroblast growth factor-4 (k-FGF) on long-term cultures of human bone marrow cells. Blood. 1996;87:1282–1291
  8. Gabrilove JL, Wong G, Bollenbacher E, White K, Kojima S, Wilson EL. Basic fibroblast growth factor counteracts the suppressive effect of transforming growth factor-beta 1 on human myeloid progenitor cells. Blood. 1993;81:909–915
  9. Fortunel NO, Hatzfeld A, Hatzfeld JA. Transforming growth factor-beta: pleiotropic role in the regulation of hematopoiesis. Blood. 2000;96:2022–2036
  10. Hino M, Suzuki K, Yamane T, Sakai N, Kubota H, Koh KR, et al.  Ex vivo expansion of mature human neutrophils with normal functions from purified peripheral blood CD34+ haematopoietic progenitor cells. Br. J. Haematol. 2000;109:314–321
  11. Ohta K, Yamane T, Koh KR, Ohta T, Nakamae H, Takubo T, et al.  An effective method for recovering CD34 positive progenitor cells from peripheral blood stem cell apheresis products cryopreserved with simplified method. Osaka City Med. J. 1999;45:139–148
  12. Yamane T, Hino M, Ohta K, Nakao T, Nakamae H, Yamamura R, et al.  Peripheral blood stem cell transplantation for non-Hodgkin’s lymphoma in complete remission. Osaka City Med. J. 1998;44:219–223
  13. Lisovsky M, Savchenko VG. Defect of stromal microenvironment in long term bone marrow cultures of patients with acute and chronic myelogenous leukemias. Leuk. Lymphoma. 1995;19:145–152
  14. Mayani H, Guilbert LJ, Clark SC, Belch AR, Janowska-Wieczorek A. Composition and functional integrity of the in vitro hemopoietic microenvironment in acute myelogenous leukemia: effect of macrophage colony-stimulating factor. Exp. Hematol. 1992;20:1077–1084
  15. Heinrich MC, Dooley DC, Keeble WW. Transforming growth factor beta 1 inhibits expression of the gene products for steel factor and its receptor (c-kit). Blood. 1995;85:1769–1780
  16. Sparrow RL, O’Flaherty E, Blanksby TM, Szer J, Van Der Weyden MB. Perturbation in the ability of bone marrow stroma from patients with acute myeloid leukemia but not chronic myeloid leukemia to support normal early hematopoietic progenitor cells. Leuk. Res. 1997;21:29–36
  17. Hassan HT, Hinz T, Kroger N, Zeller W, Zander AR. Factors influencing platelet recovery after autologous transplantation of G-CSF-mobilized peripheral blood stem/progenitor cells following myeloablative therapy in 50 heavily pretreated lymphoma patients. Clin. Lab Haematol. 1999;21:21–27
  18. Ueda M, Takanashi M, Tsubokura M, Ide T, Iwai S, Okai M, et al.  Standardization of hemopoietic colony assay reagents. Rinsho. Ketsueki. 1998;39:625–630
  19. Taipale J, Keski-Oja J. Growth factors in the extracellular matrix. Faseb J. 1997;11:51–59
  20. Nishimura T, Nakatake Y, Konishi M, Itoh N. Identification of a novel FGF, FGF-21, preferentially expressed in the liver. Biochim. Biophys. Acta. 2000;1492:203–206
  21. Niswander L, Tickle C, Vogel A, Martin G. Function of FGF-4 in limb development. Mol. Reprod. Dev. 1994;39:83–8 discussion 88–9.
  22. Eaves CJ, Cashman JD, Sutherland HJ, Otsuka T, Humphries RK, Hogge DE, et al.  Molecular analysis of primitive hematopoietic cell proliferation control mechanisms. Ann. N Y Acad. Sci. 1991;628:298–306
  23. Bierkens JG, Hendry JH, Testa NG. The radiation response and recovery of bone marrow stroma with particular reference to long-term bone marrow cultures. Eur. J. Haematol. 1989;43:95–107
  24. Laver J, Ebell W, Castro-Malaspina H. Radiobiological properties of the human hematopoietic microenvironment: contrasting sensitivities of proliferative capacity and hematopoietic function to in vitro irradiation. Blood. 1986;67:1090–1097

PII: S0145-2126(02)00033-4

Leukemia Research
Volume 26, Issue 10 , Pages 933-938 , October 2002

Article Tools

* Image Usage & Resolution